Huizenga MCW

References (3)

Title : Generate what you can make: achieving in-house synthesizability with readily available resources in de novo drug design - Hassen_2025_J.Cheminform_17_41
Author(s) : Hassen AK , Sicho M , van Aalst YJ , Huizenga MCW , Reynolds DNR , Luukkonen S , Bernatavicius A , Clevert DA , Janssen APA , van Westen GJP , Preuss M
Ref : J Cheminform , 17 :41 , 2025
Abstract :
PubMedSearch : Hassen_2025_J.Cheminform_17_41
PubMedID: 40155970

Title : Structure-Activity Relationship Studies of Aryl Sulfoxides as Reversible Monoacylglycerol Lipase Inhibitors - Jiang_2024_J.Med.Chem__
Author(s) : Jiang M , Huizenga MCW , Mohr F , Amedi A , Bakker R , van den Berg R , Deng H , van der Wel T , van Boeckel CAA , van der Stelt M
Ref : Journal of Medicinal Chemistry , : , 2024
Abstract :
PubMedSearch : Jiang_2024_J.Med.Chem__
PubMedID: 38988250

Title : A monoacylglycerol lipase inhibitor showing therapeutic efficacy in mice without central side effects or dependence - Jiang_2023_Nat.Commun_14_8039
Author(s) : Jiang M , Huizenga MCW , Wirt JL , Paloczi J , Amedi A , van den Berg R , Benz J , Collin L , Deng H , Di X , Driever WF , Florea BI , Grether U , Janssen APA , Hankemeier T , Heitman LH , Lam TW , Mohr F , Pavlovic A , Ruf I , van den Hurk H , Stevens AF , van der Vliet D , van der Wel T , Wittwer MB , van Boeckel CAA , Pacher P , Hohmann AG , van der Stelt M
Ref : Nat Commun , 14 :8039 , 2023
Abstract :
PubMedSearch : Jiang_2023_Nat.Commun_14_8039
PubMedID: 38052772